Cargando…

Phytochemicals: Potential Lead Molecules for MDR Reversal

Multidrug resistance (MDR) is one of the main impediments in the treatment of cancers. MDR cancer cells are resistant to multiple anticancer drugs. One of the major mechanisms of MDR is the efflux of anticancer drugs by ABC transporters. Increased activity and overexpression of these transporters ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinoush, Boshra, Shirdel, Iman, Wink, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317022/
https://www.ncbi.nlm.nih.gov/pubmed/32636741
http://dx.doi.org/10.3389/fphar.2020.00832
_version_ 1783550539220385792
author Tinoush, Boshra
Shirdel, Iman
Wink, Michael
author_facet Tinoush, Boshra
Shirdel, Iman
Wink, Michael
author_sort Tinoush, Boshra
collection PubMed
description Multidrug resistance (MDR) is one of the main impediments in the treatment of cancers. MDR cancer cells are resistant to multiple anticancer drugs. One of the major mechanisms of MDR is the efflux of anticancer drugs by ABC transporters. Increased activity and overexpression of these transporters are important causes of drug efflux and, therefore, resistance to cancer chemotherapy. Overcoming MDR is a fundamental prerequisite for developing an efficient treatment of cancer. To date, various types of ABC transporter inhibitors have been employed but no effective anticancer drug is available at present, which can completely overcome MDR. Phytochemicals can reverse MDR in cancer cells via affecting the expression or activity of ABC transporters, and also through exerting synergistic interactions with anticancer drugs by addressing additional molecular targets. We have listed numerous phytochemicals which can affect the expression and activity of ABC transporters in MDR cancer cell lines. Phytochemicals in the groups of flavonoids, alkaloids, terpenes, carotenoids, stilbenoids, lignans, polyketides, and curcuminoids have been examined for MDR-reversing activity. The use of MDR-reversing phytochemicals with low toxicity to human in combination with effective anticancer agents may result in successful treatment of chemotherapy-resistant cancer. In this review, we summarize and discuss published evidence for natural products with MDR modulation abilities.
format Online
Article
Text
id pubmed-7317022
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73170222020-07-06 Phytochemicals: Potential Lead Molecules for MDR Reversal Tinoush, Boshra Shirdel, Iman Wink, Michael Front Pharmacol Pharmacology Multidrug resistance (MDR) is one of the main impediments in the treatment of cancers. MDR cancer cells are resistant to multiple anticancer drugs. One of the major mechanisms of MDR is the efflux of anticancer drugs by ABC transporters. Increased activity and overexpression of these transporters are important causes of drug efflux and, therefore, resistance to cancer chemotherapy. Overcoming MDR is a fundamental prerequisite for developing an efficient treatment of cancer. To date, various types of ABC transporter inhibitors have been employed but no effective anticancer drug is available at present, which can completely overcome MDR. Phytochemicals can reverse MDR in cancer cells via affecting the expression or activity of ABC transporters, and also through exerting synergistic interactions with anticancer drugs by addressing additional molecular targets. We have listed numerous phytochemicals which can affect the expression and activity of ABC transporters in MDR cancer cell lines. Phytochemicals in the groups of flavonoids, alkaloids, terpenes, carotenoids, stilbenoids, lignans, polyketides, and curcuminoids have been examined for MDR-reversing activity. The use of MDR-reversing phytochemicals with low toxicity to human in combination with effective anticancer agents may result in successful treatment of chemotherapy-resistant cancer. In this review, we summarize and discuss published evidence for natural products with MDR modulation abilities. Frontiers Media S.A. 2020-06-19 /pmc/articles/PMC7317022/ /pubmed/32636741 http://dx.doi.org/10.3389/fphar.2020.00832 Text en Copyright © 2020 Tinoush, Shirdel and Wink http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tinoush, Boshra
Shirdel, Iman
Wink, Michael
Phytochemicals: Potential Lead Molecules for MDR Reversal
title Phytochemicals: Potential Lead Molecules for MDR Reversal
title_full Phytochemicals: Potential Lead Molecules for MDR Reversal
title_fullStr Phytochemicals: Potential Lead Molecules for MDR Reversal
title_full_unstemmed Phytochemicals: Potential Lead Molecules for MDR Reversal
title_short Phytochemicals: Potential Lead Molecules for MDR Reversal
title_sort phytochemicals: potential lead molecules for mdr reversal
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317022/
https://www.ncbi.nlm.nih.gov/pubmed/32636741
http://dx.doi.org/10.3389/fphar.2020.00832
work_keys_str_mv AT tinoushboshra phytochemicalspotentialleadmoleculesformdrreversal
AT shirdeliman phytochemicalspotentialleadmoleculesformdrreversal
AT winkmichael phytochemicalspotentialleadmoleculesformdrreversal